Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
Intended for Healthcare Professionals
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Letters

Withdrawing from SSRI antidepressants: advice for primary care

Cathy Wield
British Journal of General Practice 2023; 73 (729): 156. DOI: https://doi.org/10.3399/bjgp23X732345
Cathy Wield
Specialist in Emergency Medicine, Yeovil District Hospital, Yeovil. Email:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cathywield@gmail.com
  • Article
  • Info
  • eLetters
  • PDF
Loading

I am so glad that this article has been published.1 For some years I was saddled with a poor prognosis, told that I had a recurrent depressive disorder, and advised to take antidepressants for life. As I became more confident after the crisis had passed, returned to work, and was completely well, the side effect burden became too much. I did not know anything about tapering or that ‘withdrawal’ was a recognised entity, nor did my GP. However, I was very aware of the effects of missing a dose, which led to what are known as ‘brain zaps’, and so I cut down on venlafaxine and trazodone slowly. It was fairly easy at first, but, as I got to lower doses, I was surprised at how difficult it became. Unknowingly I ‘tapered’ because I had to cut up tablets into tiny, tiny pieces and take just enough to deal with the symptoms. It took me 2 years in all to withdraw from venlafaxine. Trazadone was harder. After the last dose, I had severe rebound insomnia and after 3 nights with no sleep at all and a restlessness, which I assumed was restless legs syndrome, I couldn’t bear it any longer and put myself back on a small dose. When I finally took the last dose, I immediately developed what is now diagnosed as a ‘small fibre neuropathy’ and there are others who have similar symptoms — thought to be a protracted withdrawal syndrome. It has lasted years. However, my mental health hasn’t been better. If I had known any of this, before I agreed to take antidepressants for what in retrospect was a very reasonable ‘emotional crisis’ provoked by a conglomeration of extreme stress within difficult circumstances, I would never have agreed. But, at the time, the chemical imbalance theory of depression was widespread and pervasive. Unfortunately, I believed what I was told and thought that the experts knew best. This is a cautionary tale in the hope that it may give pause for thought. It is easy to write the first prescription, but, for the patient, it can have profound and long-lasting consequences.

  • © British Journal of General Practice 2023

REFERENCE

  1. 1.↵
    1. Palmer EG,
    2. Sornalingam S,
    3. Page L,
    4. Cooper M
    (2023) Withdrawing from SSRI antidepressants: advice for primary care. Br J Gen Pract, DOI: https://doi.org/10.3399/bjgp23X732273.
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 73 (729)
British Journal of General Practice
Vol. 73, Issue 729
April 2023
  • Table of Contents
  • Index by author
Download PDF
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Withdrawing from SSRI antidepressants: advice for primary care
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Withdrawing from SSRI antidepressants: advice for primary care
Cathy Wield
British Journal of General Practice 2023; 73 (729): 156. DOI: 10.3399/bjgp23X732345

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Withdrawing from SSRI antidepressants: advice for primary care
Cathy Wield
British Journal of General Practice 2023; 73 (729): 156. DOI: 10.3399/bjgp23X732345
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • REFERENCE
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • Author response
  • Ethnicity did not predict performance in GP licensing of doctors entering GP training
  • Short stature — what specific test should we request?
Show more Letters

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2023 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242